Latest erythema Stories

2014-06-18 08:28:09

-- Latest psychological research reveals rosacea redness creates negative first impressions putting sufferers at a disadvantage -- Rosacea remains under-diagnosed, yet diagnosis is a critical first step to better symptom control THORNHILL, ON, June 18 2014 /CNW/ - Sex and the City actress Cynthia Nixon today spoke out about her experience of rosacea in support of 'Act on Red', a new global disease awareness program urging fellow sufferers to seek help for their...

2010-08-05 07:30:00

MALVERN, Pa., Aug. 5 /PRNewswire/ -- Vicept Therapeutics, Inc., a privately held specialty biopharmaceutical company, announced positive results today from a pharmacodynamic and pharmacokinetic clinical trial of the Company's lead product V-101, a topical cream under investigation for the treatment of erythema in patients with rosacea. The double-blinded, placebo-controlled, crossover clinical trial of 22 patients with rosacea was designed to evaluate the bioavailability of V-101 and...

2008-09-18 09:00:11

Incyte Corporation (Nasdaq:INCY) reported positive results from two 28-day Phase IIa clinical trials of topical INCB18424, a selective janus-associated kinase (JAK) inhibitor, in patients with mild to moderate psoriasis. Results from the first study (Study 201), a Phase IIa dose-escalation trial involving 28 patients, demonstrated that INCB18424 was well tolerated at all doses and significantly improved overall total lesion score and each component of the total lesion score (thickness,...

2008-07-24 21:00:19

By Dr. Helen Minciotti Mom and dad showed up on time for their newborn's first outpatient exam. That was already quite an accomplishment, considering the packing and infant bundling needed before venturing out in the frigid winter air. The 4-day-old was already gaining weight and looking great, but his parents had some concerns about his skin. The little guy did have a funny-looking rash, but one that I've seen on many other newborns. Clusters of raised yellow lesions were surrounded by...

2008-06-25 09:02:22

Merck & Co., Inc. announced today that the US Food and Drug Administration (FDA) has issued a complete response letter regarding the supplemental biologics license application (sBLA) for the use of GARDASIL(R) in women ages 27 though 45. The agency issued the letter to advise that it has completed its review of the submission and that there are issues that preclude approval of the supplement within the expected review timeframe. Merck has already discussed with FDA their questions related...

Word of the Day
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.